Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024.

Autor: Vaughan AM; These authors contributed equally as first authors.; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Afzal M; These authors contributed equally as first authors.; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Nannapaneni P; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Leroy M; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Andrianou X; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Pires J; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Funke S; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Roman C; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Reyes-Uruena J; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Aberle S; Medical University of Vienna, Centre for Virology, Vienna, Austria., Aristodimou A; Medical and Public Health Services, Nicosia, Cyprus., Aspelund G; Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland., Bennet KF; United Kingdom Health Security Agency, London, United Kingdom., Bormane A; Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia., Caraglia A; Ministry of Health, Rome, Italy., Charles H; United Kingdom Health Security Agency, London, United Kingdom., Chazelle E; Santé publique France, the French National Public Health Agency, Saint-Maurice, France., Christova I; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria., Cohen O; Division of Epidemiology, Ministry of Health, Jerusalem, Israel., Constantinou C; Medical and Public Health Services, Nicosia, Cyprus., Couvreur S; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Diaz A; National Centre of Epidemiology, CIBER in Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain., Fabiánová K; National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia., Ferraro F; Ministry of Health, Rome, Italy., Grenersen MP; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Grilc E; NIJZ (NIPH), Centre for Communicable Diseases, Ljubljana, Slovenia., Hannila-Handelberg T; Finnish Institute for Health and Welfare, Helsinki, Finland., Hvass AK; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Igoe D; HSE Public Health: National Health Protection Office, Dublin, Ireland., Jansen K; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Janță D; National Institute of Public Health, Bucharest, Romania., Kaoustou S; Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece., Koch A; Department of Infectious Diseases, Rigshospitalet University Hospital, Copenhagen, Denmark.; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark., Kosanovic Licina ML; Andrija Stampar Teaching Institute of Public Health, Zagreb, Croatia., Krumova S; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria., Labutin A; Swiss Federal Office of Public Health, Bern, Switzerland., Lachmann R; Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Lecompte A; Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium., Lefrançois R; Santé publique France, the French National Public Health Agency, Saint-Denis, France., Leitena V; Center for Disease Prevention and Control of Latvia, Department of Infectious Diseases Risk Analysis and Prevention, Riga, Latvia., Liitsola K; Finnish Institute for Health and Welfare, Helsinki, Finland., Mlinarić I; Croatian Institute of Public Health, Division for Epidemiology of Communicable Diseases, Zagreb, Croatia., Mor Z; School of Health Sciences, Ashkelon Academic College, Ashkelon, Israel.; Division of Epidemiology, Ministry of Health, Jerusalem, Israel., Neary M; HSE Health Protection Surveillance Centre, Dublin, Ireland., Novacek A; Austrian Agency for Health and Food Safety, Vienna, Austria., Øgle MW; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Orlíková H; Department of Epidemiology and Biostatistics, Third Faculty of Medicine, Charles University, Prague, Czechia.; National Institute of Public Health, Centre for Epidemiology and Microbiology, Department of Infectious Disease Epidemiology, Prague, Czechia., Papadima K; Directorate of Epidemiological Surveillance and Intervention for Communicable Diseases, National Public Health Organization, Marousi, Greece., Rehn M; Public Health Agency of Sweden (PHAS), Solna, Sweden., Sadkowska-Todys M; National Institute of Public Health NIH - National Research Institute, Warsaw, Poland., Sîrbu A; National Institute of Public Health, Bucharest, Romania., Sondén K; Public Health Agency of Sweden (PHAS), Solna, Sweden., Suárez B; Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain., Thordardottir M; Centre for Health Security and Communicable Disease Control, Directorate of Health, Reykjavik, Iceland., Vasconcelos P; Public Health Emergency Centre, Directorate-General of Health (DGS), Lisbon, Portugal., Vieira Martins J; Directorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal., Zakrzewska K; National Institute of Public Health NIH - National Research Institute, Warsaw, Poland., Widdowson MA; These authors contributed equally as last authors.; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark., Gossner CM; These authors contributed equally as last authors.; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Jul; Vol. 29 (27).

Will mpox disease caused by the human Mpox virus (MPXV) result in a pandemic-like situation similar to the COVID-19 pandemic.

Autor: Kandi, Venkataramana¹ (AUTHOR) ramana20021@gmail.com

Publikováno v: Discover Public Health. 10/15/2024, Vol. 21 Issue 1, p1-15. 15p.

A MODEL PROPOSAL ON PHYSICIAN'S EXPERIENTIAL PERCEPTION OF VALUE: PHARMACEUTICAL SECTOR EXAMPLE.

Autor: SEZGİN, Semih¹ ssezgin@sinop.edu.tr, KILIÇ, Sabiha² skilic19@hotmail.com

Publikováno v: Journal of Management Theory & Practices Research (JMTPR). ara2023, Vol. 4 Issue 2, p61-86. 26p.

Factors associated with sexually transmitted shigella in men who have sex with men: a systematic review.

Autor: Siddiq, Mohammed, O'Flanagan, Holly, Richardson, Daniel, Llewellyn, Carrie D.

Publikováno v: Sexually Transmitted Infections; Feb2023, Vol. 99 Issue 1, p58-63, 6p

Antimicrobial Resistance and Human Mobility.

Autor: Desai, Angel N, Mohareb, Amir M, Hauser, Naomi, Abbara, Aula

Publikováno v: Infection & Drug Resistance; Jan2022, Vol. 15, p127-133, 7p